secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcus Biosciences, Inc. (RCUS)
CIK:        0001724521
Form:       8-K
Filed at:   2026-03-23T23:59:59+00:00
Accession:  0001724521-26-000014
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Arcus Biosciences COO Jennifer Jarrett resigns effective March 30, 2026; advisory role through June 2026
--------------------------------------------------------------------------------

- COO Jennifer Jarrett resigns effective March 30, 2026; departure not due to any disagreement with company.
- Separation agreement includes advisory services through June 30, 2026, and extends post-termination option exercise period to 12 months.
- Agreement includes a standard release of claims; final separation agreement to be filed with next 10-Q.
- No replacement for COO position has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1724521/000172452126000014/0001724521-26-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1724521/000172452126000014/rcus-20260317.htm
  HTML page:      https://secwatch.observer/filing/0001724521-26-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer